On March 25, 2019, TRIGR Therapeutics, Inc. closed the transaction. The company has also amended the terms of the transaction and received $14 million in the transaction. The company has received $5 million in its second and final tranche from new investor Handok Inc. (KOSE:A002390). Handok Inc. (KOSE:A002390) has also committed $2 million towards its next qualified financing.